Stocks
Denali Therapeutics (DNLI) Operating Income US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -213.2 | 62.7 | -295.8 | -340.7 | -196.7 | -208.1 | |||
| Changes by years, y/y, % | +360% | -129% | -572% | +15% | -42% | +33.5% | |||
Denali Therapeutics. Operating Income, bln rub
Denali Therapeutics. Operating Income, changes, %
Denali Therapeutics. Operating Income, sum by quarters, bln rub
Denali Therapeutics (DNLI) Operating Income US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Operating Income, bln rub | -120.8 | 170.5 | -113.8 | -132.6 | -132.3 | -208.1 | ||
| Changes by years, y/y, % | +82% | -378% | +6% | +26% | +9% | |||
| Changes by quarters, q/q, % | +15% | -241% | -167% | +17% | 0% | |||
